Barinthus Biotherapeutics (BRNS) Times Interest Earned (2020 - 2026)
Barinthus Biotherapeutics' (BRNS) quarterly Times Interest Earned came in at -$0.44 in Q1 2026, up 67.06% YoY from -$0.26 in Q1 2025, and up 99.95% on a QoQ basis from -$889.62 in Q4 2025.
Barinthus Biotherapeutics (BRNS) Times Interest Earned (2020 - 2026) Analysis & Trends
Barinthus Biotherapeutics (BRNS) has 7 years of Times Interest Earned data on file, last reported at -$0.44 in Q1 2026.
- Quarterly Times Interest Earned rose 67.06% year-over-year to -$0.44 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$4.03 (up 12.65% YoY) and the FY2025 annual result came in at -$1.52, up 30.88% from the prior year.
- Times Interest Earned climbed to -$0.44 in Q1 2026, from -$889.62 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of $16.19 in Q4 2022 to a low of -$2855.4 in Q4 2023.
- A 5-year average of -$335.66 and a median of -$1.09 in 2024 frame the typical range for Times Interest Earned.
- Annual changes were most pronounced in 2022 — Times Interest Earned soared 114.4% — and 2023, when it sank 17738.04%.
- Tracing BRNS's Times Interest Earned over 5 years: stood at $16.19 in 2022, then slumped by 17738.04% to -$2855.4 in 2023, then surged by 31.74% to -$1949.2 in 2024, then jumped by 54.36% to -$889.62 in 2025, then surged by 99.95% to -$0.44 in 2026.
- The last three Times Interest Earned figures came in at -$0.44 (Q1 2026), -$889.62 (Q4 2025), and -$4.65 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | Barinthus Biotherapeutics | 25.40 Mn | 25.40 Mn | - | -787.07 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.85 |
| Mar 31, 2026 | -0.44 |
| Dec 31, 2025 | -889.62 |
| Sep 30, 2025 | -4.65 |
| Jun 30, 2025 | -1.51 |
| Mar 31, 2025 | -1.33 |
| Dec 31, 2024 | -1,949.17 |
| Sep 30, 2024 | -0.56 |
| Jun 30, 2024 | -1.09 |
| Mar 31, 2024 | -0.98 |
| Dec 31, 2023 | -2,855.43 |
| Sep 30, 2023 | -0.92 |
| Jun 30, 2023 | -13.45 |
| Mar 31, 2023 | -11.14 |
| Dec 31, 2022 | 16.19 |
| Sep 30, 2022 | 0.53 |
| Jun 30, 2022 | 7.02 |
| Mar 31, 2022 | 0.25 |
| Sep 30, 2021 | -3.65 |
| Mar 31, 2021 | -2.33 |